Abstract
Early detection of cardiac angiosarcoma is usually difficult and the prognosis is very poor. We experienced a 32-year-old man with cardiac angiosarcoma who responded to multidisciplinary treatment with recombinant interleukin-2, postoperative chemotherapy (cyclophosphamide, vincristine, doxorubicin, Dacarbazine) and radiation. At 30 months after surgery, there was no evidence of recurrence or metastasis in spite of incomplete resection.
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Cardiac Tamponade
-
Chemotherapy, Adjuvant
-
Coronary Angiography
-
Cyclophosphamide / administration & dosage
-
Cyclophosphamide / therapeutic use
-
Dacarbazine / administration & dosage
-
Dacarbazine / therapeutic use
-
Doxorubicin / administration & dosage
-
Doxorubicin / therapeutic use
-
Echocardiography
-
Heart Neoplasms / diagnosis
-
Heart Neoplasms / surgery
-
Heart Neoplasms / therapy*
-
Hemangiosarcoma / diagnosis
-
Hemangiosarcoma / surgery
-
Hemangiosarcoma / therapy*
-
Humans
-
Interleukin-2 / therapeutic use
-
Magnetic Resonance Imaging
-
Male
-
Radiotherapy, Adjuvant
-
Recombinant Proteins / therapeutic use
-
Vincristine / administration & dosage
-
Vincristine / therapeutic use
Substances
-
Interleukin-2
-
Recombinant Proteins
-
Vincristine
-
Dacarbazine
-
Doxorubicin
-
Cyclophosphamide